Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 110431415 | 11043141 | 5 | F | 200907 | 20160707 | 20150417 | 20160712 | EXP | US-009507513-1504USA009829 | MERCK | 0.00 | M | Y | 95.24000 | KG | 20160712 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 110431415 | 11043141 | 1 | PS | PROPECIA | FINASTERIDE | 1 | Oral | 1 MG, QD | 20788 | 1 | MG | FILM-COATED TABLET | QD | ||||||
| 110431415 | 11043141 | 2 | SS | PROPECIA | FINASTERIDE | 1 | Oral | 1 MG, QD | 20788 | 1 | MG | FILM-COATED TABLET | QD | ||||||
| 110431415 | 11043141 | 3 | SS | FINASTERIDE. | FINASTERIDE | 1 | Oral | 1 MG, QD | 0 | 1 | MG | TABLET | QD | ||||||
| 110431415 | 11043141 | 4 | SS | FINASTERIDE. | FINASTERIDE | 1 | Oral | 1 MG, QD | 0 | 1 | MG | TABLET | QD | ||||||
| 110431415 | 11043141 | 5 | SS | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Unknown | 10 MG, QD | U | 0 | 10 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 110431415 | 11043141 | 1 | Androgenetic alopecia |
| 110431415 | 11043141 | 3 | Androgenetic alopecia |
| 110431415 | 11043141 | 4 | Androgenetic alopecia |
| 110431415 | 11043141 | 5 | Blood pressure abnormal |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 110431415 | 11043141 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 110431415 | 11043141 | Blood testosterone decreased | |
| 110431415 | 11043141 | Brain injury | |
| 110431415 | 11043141 | Depression | |
| 110431415 | 11043141 | Ejaculation disorder | |
| 110431415 | 11043141 | Endocrine disorder | |
| 110431415 | 11043141 | Erectile dysfunction | |
| 110431415 | 11043141 | Hormone level abnormal | |
| 110431415 | 11043141 | Loss of libido | |
| 110431415 | 11043141 | Male sexual dysfunction | |
| 110431415 | 11043141 | Painful ejaculation | |
| 110431415 | 11043141 | Penile size reduced | |
| 110431415 | 11043141 | Soft tissue injury | |
| 110431415 | 11043141 | Somnolence | |
| 110431415 | 11043141 | Testicular atrophy |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 110431415 | 11043141 | 1 | 200509 | 200911 | 0 | |
| 110431415 | 11043141 | 2 | 201011 | 201301 | 0 | |
| 110431415 | 11043141 | 3 | 201301 | 201404 | 0 | |
| 110431415 | 11043141 | 4 | 201404 | 201607 | 0 | |
| 110431415 | 11043141 | 5 | 2006 | 0 |